Mary Wilson
Well-known member
November 06, 2020
Today, the U.S. Food and Drug Administration authorized the first serology test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection, which are antibodies that bind to a specific part of a pathogen and have been observed in a laboratory setting to decrease SARS-CoV-2 viral infection of cells. The FDA issued an emergency use authorization (EUA) for the cPass SARS-CoV-2 Neutralization Antibody Detection Kit, which specifically detects this type of antibody.
https://www.fda.gov/news-events/pre...est-detects-neutralizing-antibodies-recent-or
---------------------------------------------------------------------------------------------------------------------------------------------------
cPass SARS-CoV-2 Neutralization Antibody Detection Kit
https://www.fda.gov/media/143584/download
Today, the U.S. Food and Drug Administration authorized the first serology test that detects neutralizing antibodies from recent or prior SARS-CoV-2 infection, which are antibodies that bind to a specific part of a pathogen and have been observed in a laboratory setting to decrease SARS-CoV-2 viral infection of cells. The FDA issued an emergency use authorization (EUA) for the cPass SARS-CoV-2 Neutralization Antibody Detection Kit, which specifically detects this type of antibody.
https://www.fda.gov/news-events/pre...est-detects-neutralizing-antibodies-recent-or
---------------------------------------------------------------------------------------------------------------------------------------------------
cPass SARS-CoV-2 Neutralization Antibody Detection Kit
https://www.fda.gov/media/143584/download